Pfizer-BioNTech Covid Vaccine Gets Nod From FDA Advisers

The video discusses the timeline for vaccine approval and distribution in the U.S., highlighting the FDA's role and the advisory committee's vote in favor of the vaccine. It addresses concerns about vaccinating younger age groups and allergic reactions. The video also covers the expected timeline for achieving herd immunity, emphasizing the need for continued precautions like mask-wearing and social distancing. The initial vaccine rollout will prioritize healthcare workers and nursing home residents, with broader distribution taking several months.

What was the advisory committee's decision regarding the vaccine?

• They voted unanimously against it.

• They voted 17 to 4 in favor of it.

• They decided to delay the decision.

• They voted 17 to 4 against it.

What concerns were raised about the vaccine?

• Its effectiveness in people over 60.

• Its effects on 16-17 year olds.

• Its cost and distribution.

• Its storage requirements.

What is the expected timeline for the vaccine's emergency clearance?

• By the end of the month.

• Sometime early next week.

• In the next few months.

• By the end of the year.

What percentage of the population needs to be immune to achieve herd immunity?

• 30-40%

• 50-60%

• 60-70%

• 80-90%

What measures should continue even after vaccination begins?

• Lockdowns.

• School closures.

• Wearing masks and social distancing.

• Travel bans.